Oncology Highlights - February 2019
The Human Tumor Atlas Network (HTAN), barcoding single cells, FDA&EMA approvals, M&A oncology in February
SMS-oncology sets out to improve patient recruitment for clinical trials
Drug development crucially relies on accurately designed and well recruiting clinical trials. However, low accrual rates of clinical trials and unmet recruitment targets have been global attention points for many years. A 70-80...